UMedic Group Bhd

UMedic Group Bhd EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of UMedic Group Bhd (UMC.KL) as of Oct 17, 2026 is 8.93 M MYR. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 9.47 M MYR — a change of -5.66% (lower).

EBITDA

8.93 MMYR

YoY

-5.66%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of UMedic Group Bhd is 2026 8.93 M MYR. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of UMedic Group Bhd was 2025 9.47 M MYR. It decreases by -5.66% lower compared to the previous year.

The UMedic Group Bhd EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2020
3.51 M MYR
Jan 1, 2021
6.68 M MYR
Jan 1, 2022
8.63 M MYR
Jan 1, 2023
13.18 M MYR
Jan 1, 2024
12.78 M MYR
Jan 1, 2025
9.47 M MYR
Jan 1, 2026
8.93 M MYR
The UMedic Group Bhd EBITDA history
YEAREBITDAYoY
8.93 MMYR-5.66%
9.47 MMYR-25.89%
12.78 MMYR-3.10%
13.18 MMYR+52.74%
8.63 MMYR+29.24%
6.68 MMYR+90.52%
3.51 MMYR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

UMedic Group Bhd Stock analysis

What does UMedic Group Bhd do? UMedic Group Bhd is an investment holding company listed on 26 July 2022, headquartered in Penang, Malaysia. Operating within the Health Care sector, the firm engages in the marketing, distribution, and manufacturing of medical devices and consumables. Through its subsidiaries, it provides hospital furniture, life-support solutions, patient monitoring systems, and anesthesia solutions, alongside after-sales services such as clinical training and equipment pre-checks. Additionally, the manufacturing segment develops and markets specific medical consumables, including HydroX series prefilled humidifiers and AirdroX series inhaler spacers. The company serves the healthcare industry by supplying essential medical equipment and supporting services to hospitals and medical facilities. UMedic Group Bhd is one of the most popular companies on Eulerpool.

Frequently Asked Questions about UMedic Group Bhd stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of UMedic Group Bhd is 8.93 M MYR in 2026.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of UMedic Group Bhd changed from 9.47 M MYR to 8.93 M MYR, representing a -5.66% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) UMedic Group Bhd since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s MYR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s UMedic Group Bhd historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — UMedic Group Bhd

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — UMedic Group Bhd